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Plain English summary
Patient safety is a growing research area. However, although patients and the public
are increasingly involved in clinical research, there is little guidance on how best to
involve patients in patient safety research. Here we focus on how patients can
contribute to the design of patient safety research.
We conducted a workshop with patients as part of a project exploring errors and
safety in the delivery of intravenous medication (medication given via a vein). The
workshop was designed to explore how best to engage with hospital inpatients
about these issues, to generate research topics, and to inform researchers about
patients’ experiences. Nine patients participated, each of whom had previously
received intravenous medication. Participants advised against using terms such as
‘error’; they also advocated caution when using terms such as ‘safety’ when
describing the study to patients as this may worry some who had not thought
about these issues before. We received thorough and useful feedback on our
patient information sheets to ensure they were clear and understandable to
patients. Patients also shared rich experiences with us about their treatment, which
emphasised the need to extend our research focus to include a wider range of
factors affecting quality and safety.
Abstract
Background Patient safety has attracted increasing attention in recent years. This
paper explores patients’ contributions to informing patient safety research at an
early stage, within a project on intravenous infusion errors. Currently, there is little
or no guidance on how best to involve patients and the wider public in shaping
patient safety research, and indeed, whether such efforts are worthwhile.
Method We ran a 3-hour workshop involving nine patients with experience of
intravenous therapy in the hospital setting. The first part explored patients’
experiences of intravenous therapy. We derived research questions from the
resulting discussion through qualitative analysis. In the second part, patients were
asked for feedback on patient information sheets considering both content and
clarity, and on two potential approaches to framing our patient information: one
that focused on research on safety and error, the other on quality improvement.
(Continued on next page)
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Results The workshop led to a thorough review of how we should engage with
patients. Importantly, there was a clear steer away from terms such as ‘error’ and
‘safety’ that could worry patients. The experiences that patients revealed were also
richer than we had anticipated, revealing different conceptions of how patients
related to their treatment and care, their role in safety and use of medical devices,
the different levels of information they preferred, and broader factors impacting
perceptions of their care.
Conclusion Involving patients at an early stage in patient safety research can be of
great value. Our workshop highlighted sensitivities around potentially worrying
patients about risks that they might not have considered previously, and how to
address these. Patient representatives also emphasised a need to expand the focus
of patient safety research beyond clinicians and error, to include factors affecting
perceptions of quality and safety for patients more broadly.
Keywords: Patient and public involvement, Patient safety, Medication error,
Intravenous medication, Health services research
Background
Patient safety and the role of patients
Patient safety is a global health issue [27]. The Institute of Medicine’s report To Err is
Human estimated that between 44,000 and 98,000 Americans die each year due to
medical error [13]. Even assuming the lower estimate, this suggests it is the eighth lead-
ing cause of death in America, with more people dying from medical error than motor
vehicle accidents every year. Similarly grim statistics are contained within the NHS
report An Organisation with a Memory, which estimates that around 1 in ten patients
admitted to NHS hospitals will experience an adverse event [5]. Among these statistics
are real stories of human tragedy. Increased awareness of unacceptable levels of pre-
ventable patient harm has led to global efforts to improve patient safety and increased
research in this field [27, 28].
Despite patients being the main stakeholder in their care, their potential contribution
to patient safety was largely ignored until the turn of the millennium [26]. Such contri-
butions could help with reaching an accurate diagnosis, choosing appropriate treatment
plans, monitoring treatment and conditions, recognising and reporting adverse events,
improving how incident reporting is handled, and putting pressure on policy makers to
improve standards [15, 26]. The patient’s potential contribution is particularly import-
ant because they and their families are the only people present along the entire con-
tinuum of care in which they engage with multiple healthcare providers from different
disciplines, and sometimes from different facilities [27].
Patient participation and involvement in patient safety is sometimes seen as a single
broad area [14]. However, it is important to distinguish between patients and the public
participating in safety practices and involving patients in research on patient safety. For
example, the former would include a patient confirming which limb a surgeon will op-
erate on, whereas the latter would include patients advising researchers on the design
of research studies. Previous research has investigated the role of patients in their own
care and the co-production of patient safety in practice (e.g. [6, 10, 26]), but there is
little published work on the patient’s role in shaping patient safety research.
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The patient’s role in shaping patient safety research
With respect to the patient’s role in research activities, INVOLVE [11] outline the
different types of role that patients and the public can have:
– Participation - the traditional role of patients within research where they are the
subject of research and provide data to be analysed.
– Involvement – lay people actively working with researchers who seek help and
advice on the design, management and/or conduct of research, which can also
include their active involvement in data gathering and/or data analysis.
– Engagement - dissemination of research findings and their implications to patients
and the public.
In contrast to patient participation in their own safety, patient involvement in re-
search focuses on helping to shape the research, e.g. prioritising research topics,
informing how studies should be conducted, actually conducting data gathering and
analysis, and giving advice on how to conduct engagement.
Current work on patient and public involvement (PPI) in research suggests there are
few practical examples of how it can be conducted and its potential benefits [12]. Some
positive PPI examples have been documented in response to threats of tokenism [24],
which also include details of the ethical issues and practicalities of using community re-
searchers and patients to gather data in hospital [9, 21]. These studies demonstrate the
value of PPI in their qualitative descriptions of context, experiential knowledge and
contributions to the project [23].
Recognising the special sensitivities in patient safety research, the World Health
Organization published advice on Ethical Issues in Patient Safety Research [28]. The
absence of any reference to patient and public involvement (PPI) activities in this is
notable. For example, they advise that a safety committee of expert clinicians could be
set-up to advise on how to handle sensitive issues that arise during the conduct of the
study, but they do not mention how PPI could also advise on ethical issues and how
they can be addressed before the study begins. We explore the role PPI has to play in
the early stages of patient safety research by 1) reviewing patient safety information and
psychological risk; and 2) informing research topics and sensitizing researchers to pa-
tients’ experiences. These aims were shaped by early PPI feedback on our proposal for
a project to explore errors and safety in the delivery of intravenous medication.
Reviewing psychological risk and patient safety information
When initially developing our research proposal, we sought informal feedback on our
project plans from two patient representatives. One was a patient representative from
an earlier related project and the other an acquaintance who had recently been an in-
patient, both of whom had received intravenous therapy.
The feedback received at this stage raised potential issues about the conduct of the
study. For example one of the patient representative giving feedback on our proposal
said “…for patients and relatives [the proposed project] contains too much information
regarding hazards. The patients and relatives need to have complete confidence in the
staff and equipment, almost blind faith in many instances”. This caution against
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exposing patients to details about potential errors was in stark contrast to our desire to
inform potential participants about the study in an open manner. We therefore wanted to
explore how to approach patients about patient safety issues while minimising psycho-
logical risk. Psychological risk refers to the potential to have detrimental effects on the
psychological state of the participant, e.g. raising concerns, anxieties and levels of stress.
The WHO [28] guidance notes: “Psychological risks include the possibility that re-
search participants will become emotionally distressed, fearful or anxious as a result of
their participation. For example, studies that interview patients or families about harm-
ful incidents that occurred previously or about their perceptions of the quality of care
may cause them to question the quality of their medical providers and to become anx-
ious.” WHO ([28] p.15). To support this, Rhodes et al. [20] found that, during their
research, many patients had not thought about any safety issues in depth until they
were asked. One area where PPI could make a positive contribution to patient safety
research is to review potential psychological risks and mitigating strategies from a
patient’s perspective before the study begins. This has not been reported on before.
Typical PPI activities include reviewing patient information so it is written in plain
English and more easily understood from a patient’s perspective. However, there are
not many published accounts of this in practice, and no accounts of the special sensi-
tivities associated with patient safety terminology. In their work with primary medical
care patients Rhodes et al. [20] deliberately avoided framing their research questions in
terms of ‘error’ and ‘harm’ and let patients introduce topics they considered relevant.
However, published accounts of PPI advice in this area is lacking.
Informing research topics and sensitizing researchers to patients’ experiences
The initial informal patient feedback received on our project plans also encouraged us
to investigate intravenous infusion practices from the patient’s perspective. For ex-
ample, one of the patients providing feedback informed us that, “patients have no idea
of what is going on. […] I was told next to nothing about what was going on.” We pro-
posed to involve patients as participants in our research to investigate experiences of
their intravenous infusion practices, both positive and negative. However, before doing
that we wanted to use PPI to help focus our research questions and sensitize ourselves,
as researchers, to patients’ experiences in this area.
Sensitizing researchers to patients’ experiences works at two levels: 1) by informing
the researcher’s knowledge of an area so that they are more aware of potential issues,
and 2) by informing the researcher’s emotional awareness and the experiential aspects
associated with speaking to patients around the topic of research.
As part of helping to focus our research questions we were interested to hear from our
PPI participants about their general experiences of receiving intravenous medication includ-
ing, but not limited to, the extent to which patients were involved in intravenous infusion
administration. For instance, in previous studies we had observed an indirect role for pa-
tients as a member of staff realised a mistake as they explained the intravenous medication
details to a patient [7], and a more direct role as patients silenced alarms of their infusion
pumps [8]. Although the role of patients in patient safety has been investigated generally
(e.g. [3, 4, 6, 10, 14, 17–19, 22, 26]) we know of no published accounts in the specific area
of intravenous medication infusion.
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In this paper we report on a detailed case study of a PPI workshop that has informed
the design of our patient safety research. This is the first detailed published account of
patient involvement in shaping patient safety research. We provide a description of our
PPI activity, report experiential knowledge gained through the process, and document
the PPI contribution to our project. Specifically we believe that a PPI workshop can
help to review patient information and psychological risk, inform research topics and
sensitize researchers to patients’ experiences.
Method
Study setting
Our PPI workshop took place in the context of a larger project called ECLIPSE (Exploring
the Current Landscape of Intravenous Infusion Practices and Error) [1]. ECLIPSE seeks to
investigate different intravenous infusion practices in English hospitals and how these
relate to the prevalence of error, in order to make recommendations for safer infusions.
ECLIPSE has an eight-member steering committee, one of whom is a patient represen-
tative, as well as a wider advisory group with twelve members, two of whom are patient
representatives. The three phases of research in ECLIPSE, and their associated PPI activ-
ities, are shown in Table 1. The workshop described in this paper is part of the first phase,
with the workshop being viewed as a preliminary activity to inform the planned research.
Objectives of the workshop
A PPI workshop was designed to address two main objectives:
(1) Establish how to appropriately inform and engage potential patient participants in
our research.
(2) Sensitise researchers to patients’ experiences, and shape research topics and questions
related to intravenous infusions practices and safety for Phase 2 of the study.
Recruitment and sampling
Information about the focus of the workshop, date, time, location, compensation,
requirements for attendance, and links to the wider project were posted on the project’s
Table 1 Planned activities related to the three phases in ECLIPSE
Phase Research methods Patient involvement, participation & engagement
1) Point-prevalence
study
Quantitative observational
point-prevalence study of
intravenous infusions, at 16
hospital sites
In-depth discussions with
key staff at participating sites
to understand practices
First patient and public involvement workshop to
review patient information sheets for Phases 1
and 2; and explore potential topics for investigation
in Phase 2
2) In-depth
observational study
Follow up ethnographic
study of a subsample of
participating sites to explore
practices in more detail
Interview patient participants on wards about their
intravenous infusion experiences at different sites
3) Recommendations
and summary reporting
Dialogue with participating
hospitals to jointly identify
and communicate
recommendations for best
practice
Second patient and public involvement workshop
to reflect on the results and discuss dissemination
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website (http://www.eclipse.ac.uk) and People in Research (http://www.peopleinre-
search.org), a website that advertises PPI opportunities. We also circulated the relevant
information to existing contacts. Experiencing harm was not a pre-requisite to partici-
pate; indeed we wanted ‘normal’ experiences to be the focus. Six patient representatives
were recruited via these different channels. The three patient representatives on our
steering committee and advisory group also participated. These patient representatives
had seen our project plan and so were familiar with the high-level objectives of the re-
search, but they had no involvement in organising the workshop and were largely un-
familiar with the researchers when it was held.
All nine attendees (2 male, 7 female; approximate age range 35–70) had first-hand
experience of receiving intravenous medication in hospital, and some had additional
experiences of friends and family receiving intravenous medication. One attendee was
also a qualified nurse. Some patients were familiar with patient and public involvement
activities, e.g. the steering committee member had experience of reviewing patient
information material and someone entirely external to the project had experience of
sitting on Research Ethics Committees.
Procedure
The first three authors ran the workshop on university premises. Their research inter-
ests include medication safety, the psychology of human error and human factors (i.e.
evaluating and designing products and systems while taking proper account of the
people who use them). The 3-hour workshop was organised into five parts:
1. Introduction to the workshop;
2. Patients’ experiences with intravenous infusions (in two sub-groups)
[lunch break];
3. Reporting back from the two sub-groups;
4. Review of ECLIPSE patient information sheets and discussion about how best to
engage with patient participants;
5. Wrap-up session.
During the introduction we outlined the scope and plan for our project, and the role
of the PPI workshop within it. As researchers, we recognised the benefits of a bottom-
up approach to exploring patients’ experiences in an open way - generating research
topics and themes without restriction. However, we were aware that this had to be bal-
anced with trying to remain within the remit of the project. For example, we were con-
scious that it could be considered unethical to create expectations about researching
areas that were outside the project’s remit. Participants were therefore informed about
this challenge and the project’s constraints so they could help us manage this issue.
We intentionally started by listening to patients’ experiences of receiving drugs and
fluids intravenously as this would set the context for the rest of the workshop. Given
the size of the workshop, i.e. nine patients and three researchers, we split the partici-
pants into two parallel groups to allow for in-depth discussion. There were four
patients and one researcher in one group, and five patients and two researchers in the
other. The division was made arbitrarily. Each group had a researcher with experience
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of facilitating focus group discussions. The lunch break was also strategically placed so
that conversations could continue over lunch before reporting back to the whole group
on the main topics of discussion.
In the second part of the workshop, patients were asked to provide feedback on the
patient information flyer for Phase 1 of ECLIPSE and what the Phase 1 observers
should say to patients (i.e. we had written a small introductory paragraph for Phase 1
observers to use about the project). We were not involving patients as participants in
Phase 1 and so only needed a flyer to inform them about the study taking place on the
ward. The Research Ethics Committee had already approved these. The attendees were
then given two alternative patient information sheets for Phase 2, which would be used
to seek informed consent for patient participation. One informed the patient about
ECLIPSE and the study’s aims of reducing error, and the other was framed around
quality improvement. Patients were asked about their preference and to suggest im-
provements. Documentation for Phase 2 had not been submitted to the Research Ethics
Committee at the time of the workshop.
Ethical considerations
As this was a PPI activity to shape research, rather than an activity involving patient
participation in research, NHS research ethics approval was not required. However, the
UCL Research Ethics Committee granted ethical approval (UCLIC/1213/023/Staff ) for
audio recording of the discussions and use of this in subsequent analysis. Patient repre-
sentatives were given information sheets to describe what was involved in participating
in the workshop, its objectives, data protection, compensation and reimbursement.
Each signed to confirm their consent. We sought ethical approval for this involvement
activity for two reasons: 1) this provided confirmation that we were in line with good
research practices such as fully informing the workshop participants as to what was in-
volved; and 2) to obtain consent for audio-recording the workshop discussion and
using the data in publications. A similar rationale for seeking ethical approval for a PPI
activity has been reported elsewhere [16].
Data collection
All workshop discussions were audio recorded and subsequently professionally tran-
scribed. The researchers also took notes and annotated patient information sheets to
capture patients’ feedback.
Data analysis
The transcripts and notes were reviewed. Codes and themes were identified inductively
using principles of thematic analysis [2]. Through carrying out the analysis in this way
we were able to approach the data collected in a systematic manner, thus increasing
the integrity of our analysis, which would inform our research. The resulting data set
and findings could also be shared more easily across the research project team. The
first author performed the main analysis. The second and third authors reviewed the
transcript, codes and resulting themes to identify any themes that had been overlooked.
QSR NVivo version 10 was used to facilitate this process.
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Results
The findings are presented according to our workshop objectives: 1) how to appropri-
ately inform and engage patients in our patient safety research; and 2) sensitising re-
searchers to patient experiences and exploring topics that will be further investigated
through research in Phase 2 of the project.
Informing and engaging patient participants
Two main issues were highlighted in terms of how to inform patients about the re-
search. The first was simplifying the patient information provided, and the second was
the potential for raising concerns among patients about errors or poor care.
Feedback on phase 1 flyer: simplifying patient information
The information flyer for Phase 1 had been reviewed internally within the project team,
and approved by an NHS Research Ethics Committee. However, participants expressed
concerns about both the length of the flyer, and the language used to convey information
about the study and taking part. They emphasised the need to reduce the burden on
participants, recognising that they may be very unwell when receiving this information.
Patients drew our attention to particular words and phrases that could be simplified.
For example, most patients agreed that the term ‘drip’ would be better than ‘intraven-
ous medication’, and that asking patients about ‘using’ the pump would be more easily
understood than ‘interacting’ with it. The information sheet also specified that patient
names and hospital numbers would be ‘disposed of ’ following data collection, which
they thought was a poor choice of phrasing.
Patients wanted a shorter and simpler flyer; however, one patient who had Research
Ethics Committee experience recognised that the longer format is what would be ex-
pected. The group also questioned the necessity of the legal note: “NHS Indemnity does
not offer no-fault compensation i.e. for non-negligent harm, and NHS bodies are unable
to agree in advance to pay compensation for non-negligent harm.” This was described as
‘gobbledygook’, but again the group agreed that this probably needed to be included if this
was a standard phrase.
Feedback on phase 2 information sheets: concerns about safety and compromising care
To generate discussion about how to appropriately engage with patients in Phase 2 we
provided patients with two potential versions of an information sheet. Sheet A was
framed around ECLIPSE’s focus on “understanding and reducing the prevalence of
medication error,” and sheet B was framed around “developing strategies to improve
safety.” Sheet A was quickly dismissed as unworkable as there was broad agreement
that mentioning the term ‘error’ could alarm patients. Sheet B was preferred; however,
some patients were also concerned about use of the term ‘safety’:
Patient 1: “…immediately you flag up the word safety and you’ve got people worrying.”
Further discussion suggested that safety terms could be used, but they needed to be
used with care. Patient 8 said they would be comforted to know that this work was go-
ing on and that safety was being checked. However, there was some recognition that
while this might suit some patients, it might not be comforting to others. In summary,
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workshop participants were broadly supportive of the approach used in sheet B with an
emphasis on quality improvement and improving safety rather than reducing error.
In addition, participants suggested that ‘poor’ should be deleted in the phrase “action
will be taken if researchers have concerns about poor practice” which was initially
intended to reassure patients but they thought it could raise concerns. They also did
not think the phrase ‘action will be taken’ was informative and friendly. This resonates
with existing research as patient do not want to engage in activities that can be seen to
be ‘checking up’ because they have relationships to manage between themselves and
their healthcare providers (e.g. [10]). To reassure patients who did not want to take
part, the draft information sheets stated, “This would not affect the standard of your
care.” However, there was some concern about how this statement could be interpreted
and participants suggested improvements:
Patient 6: “The other thing that I would worry about, to a degree, is the sentence, this
would not affect the standard of care you receive. […] I wouldn’t be sure whether that
was a threat.
Patient 1: You have to say that, though, don’t you?
Patient 4: You could word it to say you’ll get the same care you always would.
Patient 5: Yes, it’s about reassuring people that if they drop out, they’re not – there’s
not going to be any penalties for it, essentially, but it’s a horrible way of putting it. […]
It’s one of those things that raises more questions than it answers.”
Some also raised concern about observers ‘checking’ their prescription as this could
imply that there may be something wrong. Further, participants were keen to convey
that this was a broader study across the whole ward and the hospital so patients did
not feel their particular care was being singled out for any reason.
Informing research topics and sensitising researchers to patients’ experiences
Issues that emerged from patients sharing their experience of intravenous infusions have
allowed us to draft a list of questions to consider for the patient interviews in Phase 2,
which are broader in scope than our initial ideas and grounded in patient experiences:
– What diversity is there in the way infusions are administered and what factors
influence the patient’s perception of the quality of their care?
– To what extent do infusion practices instil patients with confidence? Do they get
the level and type of information they want? Do they understand enough about
their intravenous treatment?
– What issues do patients have with their intravenous medication administration and
infusion pumps?
– What does patient participation look like in the context of intravenous medication
administration? What factors affect patient willingness to participate in safety
behaviours related to their infusions? How interested are patients in their pumps?
Do patients interact with their own pumps, and under what circumstances?
– What information about intravenous infusions do patients think would be
useful to provide other patients? What would be the best way to share this
information, e.g. a leaflet?
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– How could intravenous infusion practice be improved from a patient’s perspective?
To demonstrate how these questions emerged from the workshop we highlight some
of the topics discussed using direct quotations to preserve the patient’s voice.
Participants reported a wide diversity in the way infusions were administered and what
influenced the quality of their care. For example, one patient complained about the lack
of information received from some staff in the emergency department, despite asking:
Patient 7: “I kind of found it quite impersonal, to be honest with you, the approach of
the nurses. […] It wasn’t really explained. […] when I asked what was going on and why
it was being flushed with water, the answer that was given was kind of grudgingly given,
as if to say, well, what’s it to do with you, you know. We’re in charge here.”
In contrast another patient felt that her care team involved her in her care, and kept
her as happy and engaged as they could, which was critical to her recovery due to the
extent of her illness and her extended isolation:
Patient 2: “In fact, during my 10 months seeing only healthcare professionals was actu-
ally really interesting because we cracked a lot of jokes, [and] some people might think
they were theatrical, they were kind of trivial, not important, but in fact, they’re very,
very important to keep the patient in focus, especially when the patient is very ill, to
keep the patient as involved as possible.”
A different patient highlighted that the attitude of staff could reveal itself and impact
their perception of care through indirect means; e.g., throwaway comments and discus-
sions between staff, when they think patients cannot hear, can have a big impact on
their confidence in their care:
Patient 6: “There was a nurse […] post-surgery, I was in the ICU for 48 h or something
and then shipped up to the ward for, I can’t remember the phrase now, but specialised
nursing. And so there was two nurses there for something like 48 h constantly […]. You
know, lots of drips and infusions and pain relief. And one of them, obviously, was really
annoyed that, as far as she was concerned, that she had to sit in a special wing. I mean,
I was fairly well conscious by this time, but still, you know, morphine going in, so you’re
sort of… so a bit cloudy and a bit vague […] and you can hear all these comments. And
she’s teaching another nurse and she was saying, you know, we shouldn’t be doing this.
We should be somewhere else in another ward, in a main ward, not in a side room like
this. This is special treatment.”
Patients empathised with staff who often had to deal with difficult jobs in difficult cir-
cumstances, and who may be having a bad day, but they also recognised the need to be
professional and thought that some staff just did not have the right attitude for the job.
Patients also reported good experiences and were full of admiration for staff who con-
tributed to their care and went out of their way to make them feel comfortable:
Patient 1: “If you think they know what they’re doing and they really want to help you,
you feel much more relaxed and much happier about them attaching things to you and
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pumping things into you and pumping them out. And the really good ones do explain
things. [One positive experience involved a member of staff waiting with me for my
chemotherapy to finish long beyond the end of his shift.] And he didn’t moan at all. We
had a long chat about holidays and where he came from [and] he just made me feel
that I wasn’t being a nuisance. […] And when you’re so anxious about the whole thing,
it makes such a difference.”
The provision of information can affect patient understanding. In one case a patient
given a patient-controlled analgesia pump for pain relief did not know how often she
could press the button and whether she could overdose. Patients also remarked on not
knowing if air in the line is a problem for them to worry about.
Patient 1: “I was going to say, you don’t know whether you should be panicking about
air in the line, do you, because as a patient, people say, you can get air in and you’ll be
dead, so that’s the modern view of it – that’s the modern myth. I don’t know to what ex-
tent it’s true but that’s the perception people have […]”
Patients also did not know why pump alarms were going off.
Patient 3: “It’s that understanding of what and why and [Patient 5] very rightly
corrected me. I said pumps go off for no reason and they go off for a reason because
something’s wrong. I think [there is a] difference [between] the repetitive alarms
when they’ve just been silenced [and] actual error alarms. I think that’s the patient
safety issue. It’s not knowing whether [staff silence the alarms because they don’t
have time to attend to actual error alarms or whether the alarm is for some sort of
repetitive alert.]”
Patient 1: “if you’re a patient, you don’t speak pump beep, beep.”
Some patients would not dream of touching their pumps whereas others, particularly
those in hospital for a long time, learnt how to use theirs to some degree.
Some participants expressed concern about their intravenous treatment being set
up properly but felt it was hard to question processes they did not understand
fully and in some cases were concerned about undermining the healthcare profes-
sional by asking questions.
Participants suggested developing a leaflet or poster or similar to improve under-
standing around intravenous infusions and pumps, to make people less frightened and
empower patients to ask questions. Participants also raised the challenge of adapting
information to the different needs of patients and their different reactions to it.
Participants were aware that the quality of staff, equipment and staffing levels would
affect their care. The maintenance and availability of equipment was raised as a specific
issue. Patients were aware of broken equipment being put aside, and shortages of
equipment that needed to be borrowed from adjacent wards, which did not instil confi-
dence in the equipment that they were relying on.
Patient 2 commented on how some staff treat the equipment “what I found with the
equipment is that in the case of some nurses, not all, but some nurses, they don’t care.
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They have no attention to detail, they don’t care about the equipment and so the equip-
ment isn’t working very well.”
The quality of equipment was brought up as a different issue as one participant felt that
kinks in giving sets could be more prevalent or problematic with cheaper products.
Discussion
Staley [23] argues that we need more details of PPI activity to understand ‘how it
works’ and what value it adds. In the following sections we outline the main contribu-
tions of our PPI workshop in shaping the design of patient safety research.
The format of the workshop, which ran like a focus group, proved to be successful.
Patients were able to compare and contrast their experiences as stories were shared and dis-
cussed in the group. This provided common themes as well as a rich source of variability. It
may not be appropriate to discuss all patient safety topics in a group format, e.g. particularly
sensitive topics might be more appropriate on a one-on-one basis. However, patients with
shared experiences are likely to be able to better empathise with one another.
Reviewing potential psychological risk and mitigating strategies for patient safety
research through PPI
The WHO’s [28] guidance on ethical issues for patient safety research draws attention
to the potential psychological risk as participating patients could be worried about pos-
sible errors. Although the WHO [28] guidance lacks any mention of PPI activities, our
workshop shows that PPI can make a positive contribution to addressing this issue in
patient safety research. Patient representatives can review research plans, anticipate
how patients might feel, and suggest mitigating strategies.
The initial PPI feedback we received when drafting the project proposal suggested
our project could increase anxiety in patients due to the issues it raises. We therefore
explored this issue in the workshop. Patients gave a clear steer away from terms such
as ‘error’ and even warned that terms such as ‘safety’ should be used with care. Others
have adopted similar approaches, e.g. Rhodes et al. [20] avoided the use of ‘error’ and
‘harm’ in their interviews with patients. This does not mean that we should not provide
information about risks, but that we need to do so in an open and honest way that
manages patient anxiety. Patients also raised other areas of concern with our patient
information material that we had not foreseen, which could be used in other patient
safety projects, e.g. to ensure that patients did not feel that they, or their care, were
being singled out for any reason.
Simplifying patient information
Reviewing patient information material is seen as a fairly standard function of patient
and public involvement; however, we have not seen many publications on this – per-
haps because it is considered trivial and uninteresting. Patients thoroughly reviewed
our materials and gave useful feedback on things that we simply did not see as re-
searchers. In particular they highlighted subtle differences in the terminology used and
the need to give full consideration to how patients may interpret particular expressions
in the context of their care, and how this could impact on patient well being.
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These recommendations have already benefited our research procedures for Phase 1
of our study (which we acted on by submitting an amendment to the research ethics
committee to make changes to the patient information sheet), and will further benefit
our planned research in Phase 2.
Research ethics committees and sponsors typically have standard formats and re-
quirements for information sheets, with which at least one participant was familiar. On
this occasion we did not challenge these conventions. However, future research could
explore shorter, simpler forms of the information sheets, removing the legal note at the
bottom of the sheet, or more radical departures from the usual requirements and
expectations of the Research Ethics Committee. Since doing the PPI workshop, our
funders have requested that a funding acknowledgement and NIHR and Depart-
ment of Health disclaimer is added to every information sheet, which may create
further challenges in creating shorter forms and reflects different stakeholders’
interests and expectations.
Informing research topics and sensitising researchers to patients’ experiences
The research questions that emerged from the workshop reflect the themes of the dis-
cussions we had around patients’ experiences of receiving intravenous infusions. This
highlighted the situated nature of experiences of receiving medication intravenously in
hospital. For example, patients might want more information but might not be given it,
patients might have become expert in their own condition over a long period of time
and feel confident in questioning medical professionals, and patients’ experiences can
be influenced by staff attitude, staffing levels, device alarms, the environment, their
own illness, their treatment and personal preferences. Similar to published findings we
found a strong interplay of complex factors that seemed to impact patients’ experiences
of the quality and safety of their infusion treatment (e.g. [20]). Indeed, it seemed diffi-
cult for patients to disentangle quality and safety issues [20].
Aspects of what was discussed have been referred to in the patient involvement in pa-
tient safety literature. For example, the attitude of staff affecting whether patients will
speak up has been previously reported [6, 10, 14]. Also, it was clear that staff attitude
played a critical role in the patient’s broad experience, not just their experience of safety.
Participants expressed concern about undermining healthcare professionals by asking
questions. This resonates with previous research on speaking up about safety (e.g. [6]).
Workshop participants also expressed concern about patients raising negative issues with
the researchers as it could compromise their relationship with staff (e.g. [6, 10, 14]).
In our ongoing research we will need to consider research into patient’s involvement
in detecting, preventing and recovering from error [25], and patients’ reactions to
alarms [19]. However, we are not aware of specific studies looking at the patient experi-
ence of intravenous infusion practices, and so the experiences shared in this PPI exer-
cise provide a good foundation for our research.
Challenges/limitations
The participants in this workshop described diverse experiences of different types of
care as patients who had received intravenous infusions. However, we recognise that
patients who take part in PPI activities may not be representative of the patient
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population in general. For example, one patient was a nurse and a number of par-
ticipants had previous experience of involvement in research studies, research
steering groups, or Research Ethics Committees in addition to their experiences as
patients. Nonetheless, these patients provided rich detail about their patient experi-
ences that contributed valuable insights, and they were able to view the problem
from different angles.
Patients’ attitudes towards and expectations of healthcare services will be affected by
their experience of harm. For example, a patient who has lost confidence in the healthcare
service will be less likely to passively submit himself or herself to treatment. Experiencing
harm was alluded to by at least one participant in the workshop, and both positive
and negative experiences were reported more broadly. However, the direct relation-
ship between experience of harm and the patient’s perspective of care was not
explored in the workshop.
Furthermore, we asked patients to share their stories and experiences of intravenous
infusions, and to provide feedback on the information sheets. Our data may therefore
include a mixture of their own specific needs and their assumed needs of other
patients. Further research could tease out any differences between these perspectives.
Conclusion
There is a lack of literature on PPI for shaping patient safety research, either in showing
how it can be conducted or the value it can bring. We have reported on three out-
comes that show a clear contribution to our patient safety project: reviewing potential
psychological risk to patient participants, simplifying patient information materials, and
generating topics to pursue in research. There has also been great value in sensitizing
the researchers to patients’ experiences in this area before we speak to patients at their
bedsides on wards. These lessons could be of broader value to researchers in patient
safety. For example, high profile advice has been published on how to handle ethical is-
sues in patient safety research [28], but this does not include any form of PPI. This case
study shows how PPI activities can positively contribute to this area.
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